CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Biotinylated

TargetMol Chemicals

CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Biotinylated

16

Research Use Only

26.4 kDa (predicted). Due to glycosylation, the protein migrates to 38-50 kDa based on Tris-Bis PAGE result.

CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Biotinylated is expressed in HEK293 mammalian cells with N-His and C-Avi tag. The predicted molecular weight is 26.4 kDa and the accession number is Q5QGZ9-2.

-20°C

12352200